 CAMBRIDGE, Mass. SALISBURY, England--BUSINESS WIRE--KalVista Pharmaceuticals, Inc. NASDAQ:KALV, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:30 a.m. ET. A live webcast of the presentation will be available on the Companys website at An audio ar 